Cormedics Elects Ploth to Board


HOUSTON, May 24, 2011 – Cormedics Corp., a developer of intrapericardial technologies (, has elected medical technology executive Louis Ploth, Jr. to the company’s board of directors.

“The deep and varied financial, management and public company experience Louis brings to the Cormedics board will be invaluable as we begin commercialization of the PeriPort™ cardiac access device,” said Cormedics President & CEO Jim Meador.

The PeriPort™ is a minimally-invasive cardiac access instrument that provides access to the exterior of the heart via the pericardial space. The initial application is to withdraw fluid from the pericardial sac (membrane surrounding the heart) to evaluate the fluid for diagnostic purposes or to remove excess fluid causing compression of the heart.

Mr. Ploth joins Meador, the company’s co-founder and co-inventor of its technologies, former Rice University President Dr. Malcolm Gillis and Michael P. Macris, M.D., Medical Director, Cardiovascular Services NW, Memorial Hermann Hospital System, on the four-member Cormedics board. The company’s co-founder with Meador, Stephen R. Igo is a technical advisor to the company.

Ploth is the founder of Corporate Administrative Solutions, Inc. most recently served as chief financial officer and a member of the board of directors of Repros Therapeutics Inc. Previously he was vice president, finance and administration and CFO of Unisyn Technologies subsidiary of Synbiotics Corporation, and earlier as controller of Plant Industries, Inc. Mr. Ploth received his B.S. in Business Administration from Montclair State University.

# # #

(click here for pdf)